News

Secondary analyses showed that APOE ε4 carriers were also at greater risk for intraparenchymal hemorrhage (HR, 3.70; 95% CI, 1.36-8.38), though no significant differences were observed for ischemic ...
GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.
From 2013 to 2018, older adults with heart failure, stroke, and hypertension experienced significant declines in LE8 scores.
HealthDay News — Adults with hearing loss (HL) with hearing aids have a reduced risk for dementia, according to a research letter published online Aug. 18 in JAMA Neurology.
The researchers found that students with autism reported significantly higher rates of anxiety (64.5 percent) and depression (48.2 percent) versus peers without autism (9.4 and 7.6 percent, ...
Risk for retinal vein occlusion (RVO) is higher among patients with obstructive sleep apnea (OSA), according to results of a retrospective cohort study published in Eye.
The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.
A survey of mothers of children with Down syndrome reveals room for improvement to better support parental understanding.
A discussion regarding the link between anger, stress and cardiovascular events with Dr Viola Vaccarino and Dr Elizabeth Vella.
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.
For patients 50 years and older at high cardiovascular risk without diabetes or prior stroke, an intensive SBP target seems cost-effective.
The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.